Herantis Financial Statements From 2010 to 2025
| HRTIS Stock | EUR 1.64 0.01 0.61% |
Check Herantis Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Herantis Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Herantis financial statements analysis is a perfect complement when working with Herantis Pharma Valuation or Volatility modules.
Herantis |
Herantis Pharma Oyj Company Current Valuation Analysis
Herantis Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Herantis Pharma Current Valuation | 25.86 M |
Most of Herantis Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Herantis Pharma Oyj is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Herantis Pharma Oyj has a Current Valuation of 25.86 M. This is 99.82% lower than that of the Pharmaceuticals sector and 99.44% lower than that of the Health Care industry. The current valuation for all Finland stocks is 99.84% higher than that of the company.
Herantis Pharma Oyj Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Herantis Pharma's current stock value. Our valuation model uses many indicators to compare Herantis Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Herantis Pharma competition to find correlations between indicators driving Herantis Pharma's intrinsic value. More Info.Herantis Pharma Oyj is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Herantis Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Herantis Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Herantis Pharma Financial Statements
Investors use fundamental indicators, such as Herantis Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Herantis Pharma's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Herantis Pharma Oyj, a drug development company, focuses on developing regenerative therapeutics. The company was founded in 2008 and is based in Espoo, Finland. Herantis Pharma operates under Pharmaceuticals And Biosciences classification in Finland and is traded on Helsinki Exchange. It employs 13 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Herantis Stock
Herantis Pharma financial ratios help investors to determine whether Herantis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Herantis with respect to the benefits of owning Herantis Pharma security.